These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 3005205

  • 1. Hypomethylation of c-myc and epidermal growth factor receptor genes in human hepatocellular carcinoma and fetal liver.
    Kaneko Y, Shibuya M, Nakayama T, Hayashida N, Toda G, Endo Y, Oka H, Oda T.
    Jpn J Cancer Res; 1985 Dec; 76(12):1136-40. PubMed ID: 3005205
    [Abstract] [Full Text] [Related]

  • 2. Site-specific hypomethylation of the c-myc oncogene in human hepatocellular carcinoma.
    Nambu S, Inoue K, Saski H.
    Jpn J Cancer Res; 1987 Jul; 78(7):695-704. PubMed ID: 3040653
    [Abstract] [Full Text] [Related]

  • 3. [Correlation between hypomethylation of c-myc and c-N-ras oncogenes and pathological changes in human hepatocellular carcinoma].
    Shen L, Qui D, Fang J.
    Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):173-6. PubMed ID: 10920889
    [Abstract] [Full Text] [Related]

  • 4. [Analysis of DNA methylation pattern of c-myc oncogene in hepatocellular carcinoma].
    Xiao W, Liu W, Lu Y.
    Zhonghua Yi Xue Za Zhi; 1996 Jul; 76(7):501-4. PubMed ID: 9275498
    [Abstract] [Full Text] [Related]

  • 5. Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
    Kiss A, Wang NJ, Xie JP, Thorgeirsson SS.
    Clin Cancer Res; 1997 Jul; 3(7):1059-66. PubMed ID: 9815784
    [Abstract] [Full Text] [Related]

  • 6. c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas.
    Arbuthnot P, Kew M, Fitschen W.
    Anticancer Res; 1991 Jul; 11(2):921-4. PubMed ID: 1648336
    [Abstract] [Full Text] [Related]

  • 7. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
    Vorce RL, Goodman JI.
    J Toxicol Environ Health; 1991 Nov; 34(3):367-84. PubMed ID: 1658350
    [Abstract] [Full Text] [Related]

  • 8. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
    Tiniakos D, Spandidos DA, Kakkanas A, Pintzas A, Pollice L, Tiniakos G.
    Anticancer Res; 1989 Nov; 9(3):715-21. PubMed ID: 2548435
    [Abstract] [Full Text] [Related]

  • 9. Genomic abnormalities in hepatocarcinogenesis. Implications for a chemopreventive strategy.
    Pascale RM, Simile MM, Feo F.
    Anticancer Res; 1993 Nov; 13(5A):1341-56. PubMed ID: 8239505
    [Abstract] [Full Text] [Related]

  • 10. Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma.
    Daveau M, Scotte M, François A, Coulouarn C, Ros G, Tallet Y, Hiron M, Hellot MF, Salier JP.
    Mol Carcinog; 2003 Mar; 36(3):130-41. PubMed ID: 12619035
    [Abstract] [Full Text] [Related]

  • 11. [Expression of cellular oncogenes in human hepatocellular carcinoma cell line BEL 7402 and the effect of sodium butyrate on the expression of cellular oncogenes].
    Li SY.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Jun; 12(3):227-30. PubMed ID: 1964112
    [Abstract] [Full Text] [Related]

  • 12. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
    Vorce RL, Goodman JI.
    Mol Toxicol; 1989 Jun; 2(2):99-116. PubMed ID: 2702305
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Correlation between DNA methylation and pathological changes in human hepatocellular carcinoma.
    Shen L, Fang J, Qiu D, Zhang T, Yang J, Chen S, Xiao S.
    Hepatogastroenterology; 1998 Jun; 45(23):1753-9. PubMed ID: 9840141
    [Abstract] [Full Text] [Related]

  • 15. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T, Kohno K, Kuwano M, Gopas J, Kung HF, Ono M.
    Oncogene; 1996 Apr 18; 12(8):1625-33. PubMed ID: 8622882
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [HBV status and expression of ets-2, IGF-II, C-myc and N-ras in human hepatocellular carcinoma and adjacent nontumorous tissues--a comparative study].
    Lian ZR.
    Zhonghua Zhong Liu Za Zhi; 1991 Jan 18; 13(1):5-8. PubMed ID: 1653692
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A, Nosseir M, Zoheiry M, El-Ahwany E, Ghali A, El-Bassiouni N.
    APMIS; 2006 Jun 18; 114(6):420-7. PubMed ID: 16856963
    [Abstract] [Full Text] [Related]

  • 19. Expression of retroviral sequences and oncogenes in rat liver tumors induced by diethylnitrosamine.
    Hsieh LL, Hsiao WL, Peraino C, Maronpot RR, Weinstein IB.
    Cancer Res; 1987 Jul 01; 47(13):3421-4. PubMed ID: 3555772
    [Abstract] [Full Text] [Related]

  • 20. Aberrant expression and regulation of hepatic epidermal growth factor receptor in a c-myc transgenic mouse model.
    Woitach JT, Conner EA, Wirth PJ, Thorgeirsson SS.
    J Cell Biochem; 1997 Mar 15; 64(4):651-60. PubMed ID: 9093914
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.